Compared with placebo , patients on ondansetron experienced fewer days with urgency ( p < 0.001 ) , lower urgency scores ( p < 0.001 ) , reduced frequency of defaecation ( p = 0.002 ) and less bloating ( p = 0.002 ) , although pain scores did not change significantly .